Kiromic BioPharma
Kiromic BioPharma, based in Houston, Texas, focuses on developing innovative cell therapies for cancer using its proprietary DIAMOND AI and ABBIE platforms to enhance target identification and improve manufacturing processes.
Services
Kiromic BioPharma specializes in discovering and developing cell therapies with a focus on immuno-oncology. Utilizing their proprietary DIAMOND artificial intelligence platform, the company aims to enhance target identification, thereby compressing the development time and cost for cellular therapeutics. Their offerings include a robust pipeline of novel immuno-oncology applications designed to address various types of cancer.
Product Pipeline
Kiromic BioPharma has a diverse product pipeline that includes several innovative therapies. Key products in development are ALEXIS, an allogeneic CAR-T cell therapy platform that uses gamma delta T-cells to target solid cancers, and Deltacel-01, an off-the-shelf, non-viral, non-engineered GDT therapy targeting multiple tumor cell markers. Additionally, their pipeline features Isocel and Procel, two allogeneic off-the-shelf GDT CAR-T therapies that target mesothelin isoform and PD-L1, respectively.
DIAMOND AI Platform
The DIAMOND AI platform is a cornerstone of Kiromic BioPharma's strategy to reduce the time and cost associated with developing cellular therapeutics. This proprietary artificial intelligence platform enhances the identification of therapeutic targets, expediting the development cycle for novel cell therapies. The platform is particularly focused on immuno-oncology applications.
ABBIE Genetic Engineering Platform
Kiromic BioPharma is developing ABBIE, a non-viral, genetic engineering platform aimed at improving the safety, efficacy, and manufacturing efficiency of cellular therapies. This platform is designed to reduce production costs while enhancing the overall effectiveness of the therapeutic products, furthering the company's mission to advance cancer treatment.
Location
Kiromic BioPharma is located at 7707 Fannin, Suite 140, Houston, TX 77054. This location serves as the operational headquarters where the company's research, development, and business activities are concentrated.